Pharmacy

Company also plans to apply to the FDA this month for full approval of the vaccine for use in people ages 16 to 85 years

Global health activists note that patent holders must also share technical know-how and personnel

So far, more than 56 percent of American adults have received at least one dose of a COVID-19 vaccine; more than 106 million fully vaccinated

Chief medical adviser at Health Canada says evidence is that the vaccine is safe and effective in the younger age group

Risk for hip fracture increased with EPO doses of 50 to 149, 150 to 299, and ≥300 versus <50 units/kg/week

Risks for small for gestational age or low birth weight not increased with exposure to potent or very potent topical corticosteroids

Increased odds of vaccine hesitancy seen for patients aged 18 to 44 years, Black and Native Americans or Pacific Islanders, women

Women with premature atherosclerotic cardiovascular disease receive less optimal care than men

Task force recommends against use of beta-carotene, vitamin E for prevention of cardiovascular disease or cancer in adults

Time from vaccination to symptom onset varied from six to 15 days; initial presentation was headache in 11 cases